Hims & Hers says its first-ever gummy prescription is driving a high adherence rate
Hims & Hers achieved an 88% daily adherence rate with its first-ever gummy prescription medication. It's another example of how beauty brands, wellness startups and prescription drug providers are all leaning more into gummy formats.
本条来自 Modern Retail(Business / 零售),聚焦 处方药、CPG化、软糖剂型、Hims & Hers。 Expect prescription drugs to look and feel more like CPG brands as they adopt form factors like gummies and packaging like luxe glass jars to appeal to wellness-focused customers.
Hims & Hers achieved an 88% daily adherence rate with its first-ever gummy prescription medication
- Expect prescription drugs to look and feel more like CPG brands as they adopt form factors like gummies and packaging like luxe glass jars to appeal to wellness-focused customers
Hims & Hers achieved an 88% daily adherence rate with its first-ever gummy prescription medication
It's another example of how beauty brands, wellness startups and prescription drug providers are all leaning more into gummy formats
Expect prescription drugs to look and feel more like CPG brands as they adopt form factors like gummies and packaging like luxe glass jars to appeal to wellness-focused customers.
When Hims & Hers launched the Biotin + Minoxidil Gummy for hair growth back in June 2025, it was the company’s first-ever attempt at a prescription gummy product. Dan Kenger, chief design officer, said it’s part of the company’s larger strategy to differentiate itself from other prescription drug providers by offering a more contemporary look and feel.
“A big core of what we do is taking what’s happening in other industries and bringing it to pharma,” he said. “I think that’s one of our superpowers because we deal with familiar form factors from non-pharmaceutical spaces, and bring them here.” Continue reading this article on modernretail.co . Sign up for Modern Retail newsletters to get the latest on the shifting dynamics between retail’s old and new guards.
本条目归入「Brand Marketing」垂直,涉及真实话题:处方药、CPG化、软糖剂型、Hims & Hers。
· 市场:关注 处方药、CPG化 对相关品类与竞争格局的潜在影响。
· 消费者:Hims & Hers 的受众行为与偏好变化值得追踪。
· 品牌:Hims & Hers 的叙事、产品与增长动作可拆解复用。
· 渠道:内容分发与触点组合(社媒 / 电商 / 线下)的协同值得复盘。
· 涉及品牌:Hims & Hers。
· 核心话题:处方药、CPG化、软糖剂型、Hims & Hers。
· 可思考:如何把「处方药」的洞察,转化为可衡量的内容与增长动作?
面试中可引用「Hims & Hers says its first-ever gummy prescription is driving a high adherence rate」:围绕 Hims & Hers,说明你对行业动向的判断与可落地动作。
本条目相关英文术语可在「商务英语」模块按话题检索,用于外企面试表达训练。
Expect prescription drugs to look and feel more like CPG brands as they adopt form factors like gummies and packaging like luxe glass jars to appeal to wellness-focused customers.…
When Hims & Hers launched the Biotin + Minoxidil Gummy for hair growth back in June 2025, it was the company’s first-ever attempt at a prescription gummy product. Dan Kenger, chief…
When Hims & Hers launched the Biotin + Minoxidil Gummy for hair growth back in June 2025, it was the company’s first-ever attempt at a prescription gummy product. Dan Kenger, chief…